Atlas Trials

Placebo Controlled, Randomized, Double-blind, Multi-center Study to Investigate the Efficacy and Tolerability of BAY58-2667

Clinical trial NCT00559650 · TERMINATED

Trial details

NCT number
NCT00559650
Sponsor
Bayer
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Congestive Heart Failure
Start date
2007-12-01
Primary completion
2009-02-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.